| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $384K | +529.5% | +280.2% |
| Cost of Revenue | $258K | +637.1% | +180.4% |
| Gross Profit | $126K | +384.6% | +1300.0% |
| R&D Expense | $4.5M | -24.5% | +100.9% |
| SG&A Expense | $5.2M | +47.8% | +84.3% |
| Operating Income | -$10.4M | -2.3% | -91.3% |
| Pre-tax Income | $2.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $352.4M | +1.1% | — |
| Short-term Investments | $203.1M | — | — |
| Accounts Receivable | $491K | +411.5% | +679.4% |
| Inventory | $956K | +161.2% | +296.7% |
| Current Assets | $562.8M | +60.7% | — |
| Total Assets | $898.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.3M | — | — |
| Capital Expenditures | $5.5M | — | — |
| Investing Cash Flow | -$466.2M | — | — |
| Financing Cash Flow | $758.9M | — | — |
| Free Cash Flow | -$24.8M | — | — |
| +106.5% |
| +142.0% |
| Net Income | $2.4M | +106.5% | +142.0% |
| EPS (Basic) | $0.01 | +103.8% | +116.7% |
| EPS (Diluted) | $0.01 | +103.8% | +116.7% |
| +110.8% |
| +1069.3% |
| Current Liabilities | $3.6M | -8.5% | +49.5% |
| Total Liabilities | $20.3M | -32.5% | +86.3% |
| Stockholders' Equity | $877.9M | +121.7% | +1352.5% |